DMG — Dr Miele Cosmed SA Cashflow Statement
0.000.00%
- PLN344.99m
- PLN399.58m
- PLN488.35m
- 92
- 73
- 14
- 66
Annual cashflow statement for Dr Miele Cosmed SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 31.3 | 13.3 | -2.1 | 27.2 | 43.4 |
Depreciation | |||||
Non-Cash Items | 1.53 | 1.54 | 2.97 | 4.68 | 4.08 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -17.5 | 0.665 | -6.41 | -12.6 | -14.3 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 26.3 | 26.1 | 5.8 | 31.3 | 45.7 |
Capital Expenditures | -8.84 | -17.7 | -6.55 | -9.69 | -26.6 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 3.1 | 0.337 | 7.16 | -3.21 | 0.369 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Cash from Investing Activities | -5.74 | -17.4 | 0.602 | -12.9 | -26.2 |
Financing Cash Flow Items | -1.75 | -1.42 | -3.41 | -4.39 | -4.5 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -7.41 | -15.5 | -8.35 | -13.4 | -13.4 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 13.1 | -6.81 | -1.95 | 4.91 | 6.11 |